# Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

> **NCT01055106** · PHASE2 · COMPLETED · sponsor: **Graceway Pharmaceuticals, LLC** · enrollment: 255 (actual)

## Conditions studied

- Vaginosis, Bacterial
- Vaginal Infection

## Interventions

- **DRUG:** GW05
- **DRUG:** GW05
- **DRUG:** GW05
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT01055106
- **Lead sponsor:** Graceway Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2011-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055106, "Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01055106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*